Barbara Ann Karmanos Cancer Institute Site#159 — Detroit, Michigan

Barbara Ann Karmanos Cancer Institute Site#159 is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Barbara Ann Karmanos Cancer Institute Site#159 has participated in 1 clinical trials.

Therapeutic areas: Relapsed/Refractory Peripheral T-cell Lymphoma.

Sponsors: Taiho Oncology, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Detroit

Browse all research sites in Michigan · View every site in Detroit

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Barbara Ann Karmanos Cancer Institute Site#159?

Barbara Ann Karmanos Cancer Institute Site#159 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Barbara Ann Karmanos Cancer Institute Site#159 conducted?

Barbara Ann Karmanos Cancer Institute Site#159 has 1 clinical trials on record. Their work covers Relapsed/Refractory Peripheral T-cell Lymphoma.

Is Barbara Ann Karmanos Cancer Institute Site#159 accredited by Crixeo Clinical Trials?

Barbara Ann Karmanos Cancer Institute Site#159 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Barbara Ann Karmanos Cancer Institute Site#159?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.